Company Number: 15055533

Analysis Date: 2025-07-20 15:59 UTC

Financial Health Assessment for PJSPEAR LTD

---

1. Financial Health Score: C

Explanation:
PJSPEAR LTD shows basic operational presence with positive net assets but exhibits signs of working capital strain and limited financial robustness typical of a very young micro-entity. The company is still in its infancy (incorporated in 2023), so while no distress signals are evident, its financial "immune system" is still developing. The score C reflects a stable but fragile financial condition with room for improvement in liquidity and capitalization.

---

2. Key Vital Signs

Metric	Value	Interpretation
Fixed Assets	£857	Minimal investment in long-term assets, typical for a start-up.
Current Assets	£11,335	This includes cash and near-cash assets; essential for day-to-day operations.
Current Liabilities	£12,107	Short-term debts are slightly higher than current assets, indicating working capital deficiency.
Net Current Assets (Working Capital)	-£772	Negative working capital suggests a liquidity "ache" — the company may face short-term strain in meeting immediate obligations.
Total Assets Less Current Liabilities	£85	Positive but marginal buffer after settling short-term liabilities.
Net Assets (Shareholders’ Funds)	£85	Equity base is very small, indicating limited financial "muscle".
Share Capital	£1.00	Minimal capital injection, typical for micro-entities but limiting financial flexibility.
Loans to Directors	£7,008 (unsecured, interest-free)	Indicates reliance on directors for short-term funding support, a common practice but a symptom of external funding scarcity.

---

3. Diagnosis

The financial "pulse" of PJSPEAR LTD reveals a very young micro-business just starting its operational journey. The company is currently running with a negative working capital (net current assets -£772), which is a symptom of liquidity tightness — the ability to cover immediate bills with available short-term assets is compromised. However, the net assets remain positive (£85), showing that despite the tight liquidity, the business has not accumulated losses or insolvency risk yet.

The reliance on director loans (£7,008) as unsecured, interest-free advances to support current assets suggests the business is in a fragile state but has life support from its directors. This is akin to a patient relying on an external oxygen supply—it keeps the business afloat but is not a sustainable independent condition.

The company's small fixed asset base and very limited equity capital reflect a lean operational model. The micro-entity accounting regime used reflects a simplified reporting framework fitting a small scale operation, but it means less transparency on profitability, cash flow, and other financial health indicators.

The absence of overdue filings and continued active status are positive signs of compliance and ongoing operation.

---

4. Recommendations

To strengthen financial wellness and ensure a healthier prognosis, the company should consider the following:

• Improve Liquidity Management:
  Aim to increase current assets relative to current liabilities. This can be achieved by accelerating receivables, managing payables terms better, or building a modest cash reserve to avoid negative working capital symptoms.

• Increase Capital Base:
  Consider injecting additional equity capital or seeking external funding to build a more robust balance sheet. This will enhance financial "immune response" and provide a buffer against unexpected expenses.

• Formalize Director Loans:
  While director loans provide vital short-term support, formalizing repayment plans or converting some loans into equity can improve financial stability and investor confidence.

• Monitor Cash Flow Closely:
  Since detailed profit and loss data is not available, the directors should maintain rigorous cash flow forecasts to prevent liquidity crises.

• Plan for Growth:
  As the company grows beyond micro size, more comprehensive financial management and reporting will be needed to diagnose and treat emerging financial symptoms early.

---